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TCTAP C-160
6 Months’ Result of the First Two Cases of Renal Sympathetic Denervation for
Resistant Hypertension: Taiwan’s Experience
Li Wei Chen
Taiwan Adventist Hospital, Taiwan
[Clinical Information]
Patient initials or identiﬁer number:
Case 1: 61-year-old male
Case 2: 66-year-old male
Relevant clinical history and physical exam:
Case 1: HTN for more than 10 years
Medications:
Nifedipine 30mg qd
Carvedilol 25mg bid
Irbesartan/ hydrochlorothiazide 150/12.5mg qd
Spironolactone 25mg qd
Ofﬁce BP: 169/80mmHg
eGFR: 62ml/min/1.73 m2
Case 2: HTN for 15 years
Also has BPH, sleep apnea
Medications:
Indapamide 1.5mg qd
Telmisartan 80mg qd
Amlodipine 5mg bid
Spironolactone 25mg qd
Bisoprolol fumarate 5mg qd
Ofﬁce BP: 148/97mmHg
eGFR: 92ml/min/1.73 m2
Relevant test results prior to catheterization:
Serum levels of cortisol, catecholamine, renin, aldosterone
Urine VMA
MRA of bilateral kidneys
[Interventional Management]
Procedural step:
A 6 French introducer sheath was inserted into the right femoral artery and 5000units
of heparin was then administered. Intravenous morphine and midazolam were also
given. The right renal artery was engaged by a 6 French internal mammary artery
catheter, and contrast arteriogram was done after 400mcg of intra-arterial nitro-
glycerin to avoid vasospasm if any. For better support a Grand Slam guide wire was
advanced into distal artery segment. The approved radiofrequency ablation catheter
(Symplicity, Ardian, Medtronic) was then introduced into distal main right renal
artery proximal to the bifurcation. Total 6 ablation points were performed.
Case Summary:
Intra-Procedural Events:
Case 1: referred pain required additional dose of morphine and midazolam
Case 2: referred pain; transient bradycardia resolved spontaneously
Procedure time: case 1: 78 mins; case 2: 72 mins
Discharge 3 days later
Follow-up Results:
One month post-RDN BP: 142/69mmHg
3 month post-RDN BP: 129/62mmHg, 123/75mmHg
eGFR after one month: 44ml/min/1.73 m2, 93ml/min/1.73 m2
Medications for HTN remains no change, except case 2 bisoprolol fumarate decreased
to 1.25mg qdj TCTAP Abstracts/CASE/Innovative Devices and Futuristic Therapies
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TCTAP C-161
IVUS Guided PCI
Zheng Ji
Tangshan Gongren Hospital, China
[Clinical Information]
Patient initials or identiﬁer number:
The patient was a 45 year-old man. He was diagnosed acute anterior wall myocardial
infarction 4 month ago, the CAG in other hospital showed serious coronary patho-
logical changes and did not undergo primary PCI.
Relevant clinical history and physical exam:
Baseline ECG showed ST elevation on leads V1-V5. Cardiac enzymes were elevated
on admission.
Relevant test results prior to catheterization:
Coronary angiography revealed 70% stenosis in LM; 99% stenosis in proximal left
anterior descending artery with TIMI grade I ﬂow at this point; 75% stenosis in the
proximal ﬁrst diagonal branch; 90% stenosis in mid-circumﬂex artery; 80% stenosis in
distal-circumﬂex artery.
Relevant catheterization ﬁndings
[Interventional Management]
Procedural step:
The patient was 13 days after myocardial infarction, shall we deal with LM and left
coronary artery lesions?or send him to CABG?
6f EBU guiding catheter; 0.014 inch BMW GUIDE-WIRE;Eagle Eye Gold Ultra-
sound catheter
uSprinter legend RX 2.520 balloon;kongou 2.520 balloon;
uExcel 3.528 stent;
no-reﬂow phenomenon!
Administered two separate doses of intracoronary nitroglycerin at 200mcg, and then
sodium nitroprusside at 200mcg
no-reﬂow phenomenon again!
Administered intracoronary nitroglycerin at 200mcg, and then sodium nitroprusside at
200mcgE/Invasive Coronary Imaging: IVUS, OCT, Spectroscopy, and Other S165
